Recombinant human gelsolin April 12, 2017 Recombinant human gelsolin Trade Name Orphan Indication The respiratory symptoms of cystic fibrosis USA Market Approval USA USA Designation Date 1994-01-12 00:00:00 Sponsor BioAegis Therapeutics, Inc.;6 East Cove Lane;Morristown, New Jersey, 07960